More importantly, recent research found that SLC26A4 is associated with hypertension and left ventricular hypertrophy index is significantly reduced in patients with SLC26A4 mutation, indicating that SLC26A4-AS1 might participate in the processes of cardiac hypertrophy (Kim et al., 2017). Here, SLC26A4 is linked to left ventricular hypertrophy.